A phase 1 study of berzosertib (M6620, VX‐970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

Berzosertib (200 mg/m<sup>2</sup> iv weekly) was safe when combined with chemoradiation but did not improve complete response rate in LA-HNSCC.

Authors

Institutions

Publication Details

Journal
Cancer
Published
2026-03-13
DOI
https://doi.org/10.1002/cncr.70346
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A phase 1 study of berzosertib (M6620, VX‐970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

Michael A. Carducci, John C. Schmitz, Darrion Mitchell, V.M. Diavolitsis et al.
Cancer
Head and Neck Cancer Studies
article

A phase 1 study of berzosertib (M6620, VX‐970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)

Michael A. Carducci, John C. Schmitz, Darrion Mitchell, V.M. Diavolitsis, Brian F. Kiesel, Taofeek K. Owonikoko, Moon J. Fenton, Barbara Ann Burtness, Susanne M. Arnold, Dan Paul Zandberg, Zhengjia Chen, Charles A. Kunos, Garrett T. Wasp, J. J. Beumer, Aarti Bhatia, Harold H. Tara, Jonathan Wesley Riess, Varinder Kaur, Priyanka Bhateja, D. M. Shin, Yuji Zhang, Malini Patel, Conor E. Steuer, Steven D. Gore, Justine Yang Bruce, Nabil F. Saba, Thomas H. Davis
article en

Abstract

Berzosertib (200 mg/m<sup>2</sup> iv weekly) was safe when combined with chemoradiation but did not improve complete response rate in LA-HNSCC.

CancerVol. 132(6)
Rutgers, The State University of New Jersey (US), University of Maryland, Baltimore (US), University of Wisconsin–Madison (US), Johns Hopkins University (US), University of Miami (US), Emory University (US), University of Pittsburgh (US), Markey Cancer Center (US), Yale Cancer Center (US), University of Illinois Chicago (US), Dartmouth Psychiatric Research Center (US), UPMC Hillman Cancer Center (US), National Cancer Institute (US), Sylvester Comprehensive Cancer Center (US), Sidney Kimmel Comprehensive Cancer Center (US), Rutgers Cancer Institute (US), Dartmouth Cancer Center, University of Virginia (US), The Ohio State University (US), University of California, Davis (US)
Openalex Percentile: Top 22%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.